Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfahlberg

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
BMJ (Clinical Research Ed.)|March 31, 1998
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control studyM Otto, J Wiltfang, E Schütz, et al.
Annals of the Rheumatic Diseases|August 15, 2002
Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptomsK Manger, R Repp, M Jansen, et al.
Annals of Neurology|September 8, 2000
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variantsI Zerr, W J Schulz-Schaeffer, A Giese, et al.
Melanoma Research|December 22, 1999
Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of CancerK F Kölmel, A Pfahlberg, G Mastrangelo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control studyB Krone, K F Kölmel, J M Grange, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patientsK F Kölmel, J M Grange, B Krone, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
BMJ (Clinical Research Ed.)|March 31, 1998
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control studyM Otto, J Wiltfang, E Schütz, et al.
Annals of the Rheumatic Diseases|August 15, 2002
Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptomsK Manger, R Repp, M Jansen, et al.
Annals of Neurology|September 8, 2000
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variantsI Zerr, W J Schulz-Schaeffer, A Giese, et al.
Melanoma Research|December 22, 1999
Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of CancerK F Kölmel, A Pfahlberg, G Mastrangelo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control studyB Krone, K F Kölmel, J M Grange, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patientsK F Kölmel, J M Grange, B Krone, et al.
Pageof 6